(RECEIVED FOR PUBLICATION MARCH 24, 1960) Five cases of aspergillosis complicating Hodgkin's disease and leukaemia are reported. The organs involved were: lungs (all five cases), stomach (Case 3); brain and meninges (Case 4); heart, kidneys, spleen, thyroid, and liver (Case 2). Cultures of Aspergillus fumigatus were obtained from the post-mortem tissues of three patients.
All the lesions in Case 2 were suppurative. The other four cases had non-suppurative lesions characterized by spreading coagulation necrosis with peripheral hyperaemia, exudation, and haemorrhage. Invasion and occlusion of blood vessels occurred frequently.
The various factors that may be responsible for the initiation and progression of the fungal infection are discussed. The available evidence suggests that Aspergillus fumigatu,s can produce toxic metabolites which are able to cause tissue necrosis and vascular damage. In patients suffering from neoplastic conditions of the lympho-reticular system, especially if steroid hormones or radiomimetic drugs are given, spreading, necrotizing lesions can develop unchecked by antibody or cellular defences. During recent years deep (systemic) fungal infections have assumed considerable importance. The increasing use of powerful antibiotics, various chemotherapeutic agents, and steroid hormones has coincided with a rising incidence of mycoses complicating other diseases, especially neoplastic conditions of the lympho-reticular system. Before these drugs were introduced, aspergillosis usually presented as a chronic bronchopulmonary disease. In a classical monograph, Rdnon (1897) described it as an occupational hazard amongst pigeonfeeders and wig-makers. Coe (1945) reported the case of a man aged 47 who had worked for 20 years in the Union Stock Yards. He noted that aspergillus is a regular inhabitant of the soil and can be isolated frequently from cereal products, unmilled grain, hay, and other stock foods. The organism was saprophytic on the grain and cornmeal used by these workers. Aspergillosis may also complicate other chronic pulmonary diseases such as carcinoma, lung abscess, tuberculosis, pneumoconiosis, and bronchiectasis (Heppleston and Gloyne, 1949; Hinson, Moon, and Plummer, 1952; Golebiowski, 1958; Finegold, Will, and Murray, 1959) . When aspergillosis complicates a generalized debilitating disease such as malignant lymphoma treated with one or more of the various drugs now in use, the fungal infection is more rapidly progressive and has an increased tendency to disseminate.
The purpose of this paper is to record five additional cases of aspergillosis complicating leukaemia and Hodgkin's disease. In particular we wish to describe in some detail the tissue reactions to the fungus in this type of case. We do not propose to review the historical or mycological aspects since these have been adequately covered by other workers (Hinson et al., 1952 ; Thom and Raper, 1945) .
Material and Methods During a period of 18 months (November, 1957, to May, 1959) aspergillosis was discovered post mortem in five patients at the Royal Marsden Hospital. The primary disease was Hodgkin's lymphoma in one case, acute myeloid leukaemia in three, and lymphatic leukaemia in one (Table I) . Over the same period, 65 necropsies were performed on patients with leukaemia or malignant lymphoma, so that the proportion showing secondary aspergillus infection was between 7 and 8%. In no case was the diagnosis of aspergillosis made during life.
Aspergillus fumigatus was isolated from post-mortem tissues in three patients (Cases 1, 2, and 5): swabs were taken from the lesions and inoculated on to Sabouraud's medium, subculturing being continued until a pure growth was procured (Fig. 1 ). In the other two cases, cultures were not obtained, but we feel that there is little doubt that the organism seen in tissue sections was an aspergillus since morphological criteria were satisfied (Torack, 1957) ; the hyphae were of medium width (10-15 p), were septate, 
Histological Observations
The naked-eye changes in Cases 1, 3, 4, and 5 correspond to a characteristic microscopic pattern of necrosis without suppuration. All the lesions in Case 2 show polymorph infiltration and pus formation. The non-suppurative and suppurative types of tissue reaction will be described separately.
Non-suppurative Lesions.-Not only do these lesions fail to suppurate but they display little evidence of any inflammatory cell response. We have designated this type of reaction as " spreading-necrotizing," a term which emphasizes the chief features. The fungal infection was confined to the lungs in Cases 1 and 5. In Case 3 there were also small foci in the trachea, pharynx, and stomach, and in Case 4 early lesions were found in the meninges and brain (Table I ). It appears that the fungus can reach the pulmonary alveoli in two ways: (1) By aspiration into the respiratory bronchioles and alveolar ducts with subsequent direct spread into the associated alveolar sacs and alveoli; (2) by colonizing the mucosa of the bronchi and then spreading through their walls. The examination of multiple blocks prepared from foci of different sizes enables one to reconstruct the evolution of the lesions and to study the effect of the fungus on various tissue components. Alveolar Foci. Under this heading we shall consider the lesions produced when the organism spreads into the lung parenchyma by the first of the two pathways mentioned. The Fungal mycelia grow within bronchial lumina and in this situation sporing heads may be seen (Fig. 14) . There is a marked tendency for the aspergillus to spread through the bronchial walls into the adjacent lung. The earliest evidence of such penetration is an area of coagulation necrosis involving the epithelium and underlying connective tissue cells (Fig. 15) . Such a segment appears granular and highly eosinophilic except in so far as there are scattered, deeply basophilic nuclear fragments. Beyond the limits of the necrosis the smooth muscle fibres are separated by oedema and the mucous glands are often greatly distended. The fungus then penetrates the dead tissue and extends outwards, a wave of necrosis preceding immediately before it. In this manner the whole thickness of the bronchial wall becomes necrotic and the hyphae reach the surrounding alveoli where they excite fibrinous exudation and haemorrhage as already described (Fig. 16) . The alveoli undergo necrosis in their turn and so the lesion extends until a large volume of lung tissue may be involved. When passing through the bronchial wall, the fungus may grow outwards between adjacent cartilage plates, but cartilage itself is by no means immune to invasion by the hyphae (Fig. 17) (McKee, 1950; Pesle and Monod, 1954; Oehlert and Duffel, 1958; Finegold et al., 1959 ; Naji, 1959 Fig. 18 . Within the lumina the hyphae often lose their basophilia and stain pink with eosin, contrasting with those portions of the fungus that are still extravascular. Whether this change of staining property is due to the deposition of eosinophilic material upon the hyphae or to some other cause is uncertain. Suitable staining procedures sometimes show a halo of radiating fibrin filaments around the hyphae (Fig. 19) While this may well occur, it seems certain that the fungus itself is able to produce large infarct-like areas of necrosis, especially in the lungs (Fig. 13) .
Gastric Lesions.-Sections of the ulcers from Case 3 show a non-suppurative tissue reaction basically similar to that already described for the lungs. Within the lesions, the mucosa has undergone coagulation necrosis to form an eosinophilic mass devoid of nuclei but still retaining vague tubular outlines. The fungus is growing in the necrotic tissue and has penetrated into the submucosa where many blood vessels have been invaded.
Vascular dilatation, sero-fibrinous exudation, and red cell extravasation are prominent in the submucous layer (Fig. 19) (Fig. 20) . The alveolar ducts and associated alveoli are filled with an exudate rich in polymorphs amongst which swollen fungal hyphae can be identified. The lesions in the myocardium, thyroid, spleen, kidneys, and liver have the usual features of suppurative inflammation and need not be described further (Figs. 21 and 22) . The pericardial exudate is composed mainly of a thick layer of fibrin, but small foci of suppuration are also present (Fig. 23) . Invasion of blood vessels, with acute arteritis, is seen in several sites, but is especially prominent in the right kidney where large vessels are involved (Fig. 24) . This has resulted in extensive infarction affecting the upper half of the organ.
Discussion
The following aspects will be considered: (1) The classification of aspergillosis and the distribution of the lesions; (2) (a) whether the disease is secondary or primary, i.e., whether a predisposing disease is or is not present; (b) the extent of spread (localized or disseminated); (c) the pathology of the lesion; and (d) the presence or absence of allergy (Hinson et al., 1952; Hinson, 1958; Finegold et al., 1959) . With regard to pulmonary disease, there are several wellcharacterized types: (1) Aspergillus bronchitis in which the fungus grows within the bronchial lumina and the mucosa shows only superficial changes (Kortge, 1952; Segretain, 1958) ; (2) allergic, in which the bronchi contain fungus, mucus, fibrin, eosinophils, Curschmann's spirals, and Charcot-Leyden crystals. The patients suffer asthmatic attacks and eosinophilia may be present in the peripheral blood (Hinson et al., 1952) ; (3) "mycetoma " or " intracavitary aspergilloma." This comprises a mycelial mass (fungus ball), usually reddish-brown, lying in a saccular dilatation of a bronchus. The bronchial epithelium is often intact and the adjacent connective tissues are infiltrated with plasmacytes, macrophages, and polymorphs in varying numbers (Monod, Pesle, and Segretain, 1951 ; Pesle and Monod, 1954; Hinson, 1958; Naji, 1959) ; (4) invasive, in which the fungus spreads beyond the confines of the bronchi into the alveolar parenchyma of the lung (Lapham, 1926; Penta, 1955; Finegold et al., 1959; Naji, 1959) .
Spread from the lungs by the blood stream may produce fungal lesions in other parts of the body such as the brain, meninges, endocardium, myocardium, pericardium, kidneys, liver, spleen, thyroid, lymph nodes, pancreas, and bones (see review by Grcevic and Matthews, 1959) . Dissemination to the brain and meninges was present 410 group.bmj.com on June 21, 2017 -Published by http://jcp.bmj.com/ Downloaded from in our Case 4. In Case 2 fungal lesions were present in the pericardium, myocardium, thyroid, spleen, kidneys, and liver. Although the respiratory tract is the usual portal of entry, the fungus can also colonize the mucosa of the alimentary tract (Welsh and McClinton, 1954; Zimmerman, 1955;  our Case 3). It is also possible that these organisms may occasionally be introduced by therapeutic injections. Wybel (1952) reported a case of mycotic granuloma of the leptomeninges in a patient who had received intrathecal injections of penicillin for pneumococcal meningitis three years before her death. The clinical course of the granuloma simulated a spinal cord tumour.
Factors Influencing Invasion of the Body by the Fungus.
The importance of environmental (occupational) factors and of pulmonary lesions has already been mentioned. Apart from this there is evidence that tissue invasion by fungi is facilitated by the administration of various antibiotics, chemotherapeutic drugs, and hormones. Keye and Magee (1956) , reviewing the incidence of fungal infections amongst 15,845 consecutive necropsies performed from 1919 to 1955, found a conspicuous increase in the number of secondary fungous infections since 1947. Histoplasmosis, cryptococcosis, mucormycosis, candidiasis, and aspergillosis had all increased. They also noted a greater tendency to systemic dissemination of the fungi during recent years. An especially high incidence was observed in cases of leukaemia and malignant lymphoma. These authors believed that the rising frequency was related to the administration of multiple antibiotics, chemotherapeutic compounds, and cortisone. Craig and Farber (1953) Finegold et al. (1959) reported 12 cases of aspergillosis. Seven were suffering from carcinoma, leukaemia, or Hodgkin's disease. Six had been given steroids. Four had received other " anti-neoplastic " therapy including irradiation to the spleen, "myleran," "leukeran," and " amethopterin."
These clinical observations are supported by experimental studies. Huppert, MacPherson, and Cazin (1953) found that aureomycin caused a significant growth stimulation of Candida albicans in broth cultures. Seligman (1953) demonstrated enhanced virulence of Candida albicans by terramycin, aureomycin, and cortisone in experimental animals. Mankowski and Littleton (1954) found that the administration of cortisone reduced the survival times of mice infected with Candida albicans, Aspergillus sp., Penicillium sp., Histoplasma capsulatum, or Cryptococcus neoformans. Sidransky and Friedman (1959) (Tomaszewski, 1951) . We consider factors (3) and (4) to be those of greatest significance in our own cases.
Certain Factors Influencing Nature of Tissue Reactions.-Baker (1947) and Symmers (1958) have described the various tissue reactions that may be found in fungal infections. The pattern varies with the type of fungus, its location, the duration of the lesion, the presence or absence of allergy, and the general condition of the host. According to the circumstances one or more of the following may be seen: intracellular parasitism, suppuration, chronic non-specific inflammatory changes, fibrosis, tuberculoid reactions, caseation, " foreign-body " reactions, and " no reaction.*9 The changes most often seen in the invasive varieties of aspergillosis are necrosis, acute inflammation, and suppuration. It will be recalled that four of our cases displayed foci of coagulation necrosis associated with exudation and haemorrhage but with a virtual absence of inflammatory cells. Necrosis and haemorrhage have been reported by other workers such as Heppleston and Gloyne (1949) , Rankin (1953) , Naji (1959) , and Grcevic and Matthews (1959 Iyer, Dodge, and Adams, 1952; Finegold et al., 1959) and experimental animals (Henrici, 1940; Cooper, 1946; Oehlert and Duffel, 1958) . Henrici (1940) studied the lesions produced in rabbits by injecting aspergillus spores. He found that massive doses produced foci of necrosis and haemorrhage. Moderate doses led to abscess formation, while small numbers of spores resulted in " tubercles " with central caseation. In lesions of the last type, the so-called actinomycetoid form of the fungus was sometimes found. This consists of short filaments of thin mycelium radiating from a portion of normal-sized mycelium; the ends of the filaments are often capped by acidophilic material. Actinomycetoid bodies have been observed in human lesions (Oehlert and Duffel, 1958) , but they were not present in our own cases. Henrici (1940) believed the epithelioid-cell granulomas and the actinomycetoid forms to be manifestations of hypersensitivity. If this is so, their absence from our cases is not surprising in view of the frequent poverty of immunological mechanisms in Hodgkin's disease (Dubin, 1947) There is no evidence that the fungus can produce a true exotoxin, although certain toxic antibiotic and tumour-inhibiting substances have been isolated from cultures of Aspergillus fumigatus (Soltys, 1944; Asheshov and Strelitz, 1945; Petermann, Hamilton, and Reilly, 1952) . Oehlert and Duffel (1958) found anisotropic crystalloid bodies within fungal networks lining the bronchi of their patient. They suggested that these crystals were toxic metabolites of the fungus. Henrici (1939) (Riddell, 1958) . In four of our cases the depression of antibody and cellular defences apparently allowed the rapid development of the lesions in a " pure " state and it was possible to study the effect of the toxic substances on different tissue components without the complicating factor of an inflammatory-cell infiltrate. Marin, and Mele, 1959) . On the other hand the hyphae in the pericardial exudate of Case 2 do not appear to have had any significant lytic effect on the fibrin in their vicinity, although digestion has occurred in the suppurative foci. It is possible that the large surface area of the serous membranes allows such an abundant exudation that the fibrin remains constantly in excess of any fibrinolytic substance diffusing from the fungus. The virtual absence of neutrophils from the peripheral blood during the last days of life probably accounts for the absence of suppuration in Cases 1, 3, 4, and 5. This interpretation accords with the findings of Torre and Leikin (1959) . Using the Rebuck skin window test these authors demonstrated a poor inflammatory response in leukaemic patients who had significant neutropenia. However, it is interesting to recall that in our Case 1, staphylococcal abscesses were present in the lungs, so that a suppurative type of inflammatory reaction was still possible; this indicates the poor pyogenic properties of aspergillus relative to the staphylococcus under identical environmental conditions. The only patient who did not have a severe terminal neutropenia (Case 2) developed widespread suppurative lesions as already described. It is possible that the toxic substances may be absorbed into the blood stream and exert an effect on distant parts of the body. Chortis (1952) recorded his clinical impression that pulmonary aspergillosis can cause toxic effects on the myocardium and central nervous system, although he produced no pathological evidence for this statement. Oehlert and Duffel (1958) found necrosis and calcification of the renal tubules in rats that had been given intraperitoneal injections of Aspergillus fumigatus. They also described fibrinoid swelling of the walls of small and medium-sized blood vessels in the livers, kidneys, and hearts of the animals. In our own cases we have been unable to find changes in distant organs that could be attributed to toxic metabolites of the aspergillus. It may, of course, be extremely difficult to distinguish between lesions produced this way and those resulting from other factors such as anaemia, cardiac failure, and therapeutic agents.
